Dr. Lauren Oshry is an Assistant Professor of Medicine at the Chobanian and Avedisian School of Medicine and a member of the section of Hematology and Oncology at Boston Medical Center. She is a Phi Beta Kappa graduate of Wellesley College and an Alpha Omega Alpha graduate of the Albert Einstein College of Medicine. She completed her internship and residency at Boston City Hospital and fellowship training in Hematology and Oncology at Beth Israel Hospital/Harvard Medical School, after which she joined the faculty of Chobanian and Avedisian School of Medicine. She has a special interest in breast and gynecologic cancers, with a focus on disparities in care as well as lifestyle modifications, including weight management and exercise, to improve outcomes.
Diversity, Equity, Inclusion and Accessibility
I am part of a dedicated team of healthcare professionals, researchers, students and staff from different countries and various regions of the U.S. The culture of our Section is defined by the unique perspectives that we each bring with us. As both a large academic medical center and safety-net hospital serving the communities of Boston and its surroundings, our trainees engage in cutting edge research and gain real-world clinical experience by caring for local underserved populations. Our multilingual team is committed to promoting cultural competency, equity and inclusion in science, medicine and healthcare. We strive to maintain a workforce that is as diverse as the communities we serve, and aim to create a safe space for our members to learn, grow and succeed in their life goals. Acknowledging that we all have a role to play, I am dedicated to welcoming and celebrating individuals of all races, ethnicities, social backgrounds, religion, gender, sex, age, ability, sexual orientation, veteran status, and national origin.
Member
Boston University
Evans Center for Interdisciplinary Biomedical Research
East Boston Neighborhood Health Center
This tab shows grant data from BMC Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from BU Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data that did not automatically get imported into Profiles
from BU or BMC sources.
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from the Boston VA. We are only showing grant title, and only for people in the role of PI.
MK-3475-355-0010/11/2017 - 03/31/2019 (PI)
Merck
|
Yr
|
Title
|
Project-Sub Proj
|
Pubs
|
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
Medford AJ, Oshry L, Boyraz B, Kiedrowski L, Menshikova S, Butusova A, Dai CS, Gogakos T, Keenan JC, Occhiogrosso RH, Ryan P, Lennerz JK, Spring LM, Moy B, Ellisen LW, Bardia A. TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Ther Adv Med Oncol. 2023; 15:17588359231152844. PMID: 36743521; PMCID: PMC9893401; DOI: 10.1177/17588359231152844;
-
Lombardi FL, Jafari N, Bertrand KA, Oshry LJ, Cassidy MR, Ko NY, Denis GV. Novel semi-automated algorithm for high-throughput quantification of adipocyte size in breast adipose tissue, with applications for breast cancer microenvironment. Adipocyte. 2020 12; 9(1):313-325.View Related Profiles. PMID: 32633194; PMCID: PMC7469507; DOI: 10.1080/21623945.2020.1787582;
-
Ko NY, Qureshi MM, Oladeru OT, Cassidy MR, Oshry L, Truong MT, Hirsch AE. Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer. Breast Cancer Res Treat. 2020 Dec; 184(3):849-859.View Related Profiles. PMID: 32888137
-
Festa K, Hirsch AE, Cassidy MR, Oshry L, Quinn K, Sullivan MM, Ko NY. Breast Cancer Treatment Delays at an Urban Safety Net Hospital Among Women Experiencing Homelessness. J Community Health. 2020 06; 45(3):452-457.View Related Profiles. PMID: 31625050
-
Kim KN, Qureshi MM, Huang D, Ko NY, Cassidy M, Oshry L, Hirsch AE. The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis. Clin Breast Cancer. 2020 04; 20(2):e200-e213.View Related Profiles. PMID: 32089454
-
Yates PA, Newman SA, Oshry LJ, Glassman RH, Leone AM, Reichel E. Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease. Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620951053. PMID: 32873175; PMCID: PMC7476338; DOI: 10.1177/1753466620951053;
-
Quintiliani LM, Foster M, Oshry LJ. Preferences of mHealth app features for weight management among breast cancer survivors from underserved populations. Psychooncology. 2019 10; 28(10):2101-2104.View Related Profiles. PMID: 31368197; PMCID: PMC6786913; DOI: 10.1002/pon.5190;
-
Crawford C, Oshry LJ, Reichel E. ATYPICAL MACULOPATHY IN A PATIENT WITH LIGHT CHAIN DEPOSITION DISEASE MIMICKING ADVANCED GEOGRAPHIC ATROPHY. Retin Cases Brief Rep. 2017 Winter; 11(1):83-85. PMID: 26934302; PMCID: PMC5214371; DOI: 10.1097/ICB.0000000000000295;
-
Goldberg RA, Reichel E, Oshry LJ. Bilateral toxoplasmosis retinitis associated with ruxolitinib. N Engl J Med. 2013 Aug 15; 369(7):681-3. PMID: 23944322; DOI: 10.1056/NEJMc1302895;
-
Wright DG, Boosalis MS, Waraska K, Oshry LJ, Weintraub LR, Vosburgh E. Tiazofurin effects on IMP-dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis. Anticancer Res. 1996 Nov-Dec; 16(6A):3349-51.View Related Profiles. PMID: 9042310
Showing 10 of 14 results.
Show More
-
Oshry L, Meers P, Mealy T, Tauber AI. Annexin-mediated membrane fusion of human neutrophil plasma membranes and phospholipid vesicles. Biochim Biophys Acta. 1991 Jul 22; 1066(2):239-44.View Related Profiles. PMID: 1830223
-
Oshry L, Meers P, Mealy T, Pavlotsky N, Tauber AI. Annexin-mediated membrane fusion in human neutrophils. Trans Assoc Am Physicians. 1991; 104:213-20.View Related Profiles. PMID: 1845148
-
Levy RJ, Howard SL, Oshry LJ. Carboxyglutamic acid (Gla) containing proteins of human calcified atherosclerotic plaque solubilized by EDTA. Molecular weight distribution and relationship to osteocalcin. Atherosclerosis. 1986 Feb; 59(2):155-60. PMID: 3083831
-
Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol. 1983 Nov; 113(2):143-55. PMID: 6605687; PMCID: PMC1916380
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 1983 | 1 |
| 1986 | 1 |
| 1991 | 2 |
| 1996 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2023 | 1 |